The Hospital del Mar Institute for Medical Research (IMIM- Hospital del Mar) will participate in four projects that will receive funding from the European Union's Horizon Europe programme. In total, around EUR 30 million will be earmarked for research in the fields of oncological surgery, oncology, obesity and mental health. Of these, almost 2.5 million will go directly to research carried out at the IMIM-Hospital del Mar.
The European Medicines Agency selected Hospital del Mar and the Hospital del Mar Medical Research Institute to be a Data Partner of the DARWIN EU® data network, an EU-wide federated network of high-quality observational healthcare databases across Europe, that provides expertise and services to support regulatory decision-making throughout the lifecycle of medicinal products.
The goal of this project is to use DNA and RNA sequencing data collected from hundreds of patients with advanced bladder cancer, including a cohort at Hospital del Mar in Barcelona, to develop predictive models of the response to immunotherapy. We expect that, by including different types of neoantigens and new molecular biomarkers in the models, we will be able to achieve higher accuracy in the predictive models. The project is undertaken by a highly multidisciplinary team led by Mar Albà. The funding is for the period 2022-2024.